The move secures AZ access to the Japanese drug giant’s experimental antibody drug conjugate
Updated Date: Mon, 20 Jul 2020 00:00:00 EDT
Updated Date: Mon, 20 Jul 2020 00:00:00 EDT
Updated Date: Mon, 20 Jul 2020 00:00:00 EDT
Updated Date: Mon, 20 Jul 2020 00:00:00 EDT
Europe’s COVID-19 vaccine negotiations hit snags with 3 drugmakers: Reuters esagonowsky Mon, 07/27/2020 – 14:58
Pfizer could earn $15B-plus in COVID-19 vaccine sales: analyst esagonowsky Mon, 07/27/2020 – 11:43
Researchers have found an unusual strategy that eventually may help to guard transplanted beta cells or to slow […]
Yemen’s already collapsing healthcare system is buckling as the coronavirus pandemic hits an infrastructure already devastated by five […]
